Novo Nordisk sweetens bid for Metsera with an offer of up to $10 billion

Nov 4 (Reuters) - Novo Nordisk NOVOb.CO is now offering up to $10 billion for Metsera MTSR.O, up from its prior offer of up to $8.5 billion, the obesity drug developer said on Tuesday.

 (Reporting by Christy Santhosh and Siddhi Mahatole in Bengaluru; Editing by Maju Samuel)

 ((Christy.Santhosh@thomsonreuters.com;))

Recent news on Metsera

See all news